VYNE Therapeutics
VYNE
VYNE
20 hedge funds and large institutions have $1.63M invested in VYNE Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less funds holding
Funds holding: 23 → 20 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$237K | |
| 2 | +$43.1K | |
| 3 | +$28.9K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.1K |
| 5 |
Morgan Stanley
New York
|
+$3.63K |
Top Sellers
| 1 | -$84K | |
| 2 | -$31K | |
| 3 | -$2.25K | |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$148 |